Leerink Swann Upgrades Forest Laboratories (FRX) to Outperform; U.S. Portfolio Warrants a Premium

May 31, 2012 7:17 AM EDT Send to a Friend
Leerink Swann upgraded Forest Laboratories (NYSE: FRX) to Outperform, price target raised from $34 to $41.

Analyst, Seamus Fernandez ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login